Research Article

Clinical Evaluation of FOXO1 as a Tumor Suppressor in Prostate Cancer

Figure 1

FOXO1 was downregulated in prostate cancer. The comparison between FOXO1 expression levels in normal prostate tissues and prostate tumors is shown in four gene expression data, namely, GSE38241 (a), GSE55945 (b), GSE6919 (c) and TCGA (d), which are all publicly available Significance holds if is below 0.05 (; ; ).
(a)
(b)
(c)
(d)